Despite substantial progress towards achieving the UNAIDS 95–95–95 targets,1 the global HIV response continues to be undermined by a multitude of complex, interrelated challenges. Persistent stigma ...

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

The global outbreak of clade IIb mpox virus has resulted in significant morbidity among HIV populations and men who have sex with ... Logistic regression models were employed for statistical analysis.

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

This model generates patterns that closely resemble the activity of actual brain cells involved in both spatial awareness (place cells and grid cells) and concept recognition (concept cells).

Doctor wearing blue gloves carefully holds a blood test tube labeled HIV in a medical clinic, showcasing a critical step in health diagnostics and patient care. Royalty-free licenses let you pay once ...

AI models can predict the lengths of time patients will spend in the ICU, helping hospitals better manage their beds and, ideally, cut costs. But although AI is good at predicting length of stay ...